Liabilities / Assets
76th percentile
Higher debt load relative to assets than 76% of similar nonprofits.
EIN 88-0234325 • 501(c)3 • Carson City, NV
Profile
To advance medical and scientific research through the transfer of technology from the laboratory to public use by obtaining patents and licenses and administering patents arising out of discoveries made pursuant to research conducted or sponsored by Clayton Foundation for Research and its supporting organizations.
Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.
Liabilities / Assets
76th percentile
Higher debt load relative to assets than 76% of similar nonprofits.
Liabilities / Revenue
93rd percentile
Higher debt load relative to revenue than 93% of similar nonprofits.
Net Margin
1st percentile
Higher net margin than 1% of similar nonprofits.
Top Officer Pay
Score unavailable
No filing with officer rows is available for this organization yet.
Asset Growth
54th percentile
Faster asset growth than 54% of similar nonprofits.
Revenue Growth
81st percentile
Faster revenue growth than 81% of similar nonprofits.
Assets
Up$51,172,587
Up $3,430,643 (+7.2%) from 2023
Liabilities
Up$29,470,044
Up $9,645,281 (+49%) from 2023
Net Assets
Down$21,702,543
Down $6,214,638 (-22%) from 2023
Revenue
Up$6,153,203
Up $1,353,121 (+28%) from 2023
Expenses
Down$15,954,732
Down $847,778 (-5.0%) from 2023
Net Income
Up-$9,801,529
Up $2,200,899 (+18%) from 2023
Most recent year
2024 • Form 990Detailed filing. Detailed filing data is available for this year.
To advance medical and scientific research through the transfer of technology from the laboratory to public use by obtaining patents and licenses and administering patents arising out of discoveries made pursuant to research conducted or sponsored by Clayton Foundation for Research and its supporting organizations.
To advance medical and scientific research through the transfer of technology from the laboratory to public use by obtaining patents, granting licenses and administering patents arising out of discoveries pursuant to research conducted or sponsored by certain other charitable organizations. As funds are available, grants are made to Clayton Foundation for Research to support additional research.
| Line | Beginning | End | Change |
|---|---|---|---|
| Assets | |||
| Investments in Publicly Traded Securities | $26,295,220 | $29,319,817 | ▲ $3,024,597 |
| Savings and Temporary Cash Investments | $14,536,859 | $13,913,997 | ▼ $622,862 |
| Accounts Receivable | $1,155,022 | $1,826,912 | ▲ $671,890 |
| Cash and Non-Interest-Bearing Accounts | $432,263 | $261,881 | ▼ $170,382 |
| Prepaid Expenses and Deferred Charges | $92,211 | $51,199 | ▼ $41,012 |
| Other Notes and Loans Receivable, Net | - | $0 | - |
| Pledges and Grants Receivable | - | $0 | - |
| Receivable From Disqualified Prsn | - | $0 | - |
| Receivables From Officers Etc | - | $0 | - |
| Investments Other Securities | - | $0 | - |
| Investments Program Related | - | $0 | - |
| Land, Buildings, and Equipment, Net | - | $0 | - |
| Intangible Assets | - | $0 | - |
| Inventories for Sale or Use | - | $0 | - |
| Total Assets | $47,741,944 | $51,172,587 | ▲ $3,430,643 |
| Other Assets Total | $5,230,369 | $5,798,781 | ▲ $568,412 |
| Liabilities | |||
| Deferred Revenue | $18,776,939 | $28,348,292 | ▲ $9,571,353 |
| Accounts Payable and Accrued Expenses | $1,047,824 | $1,121,752 | ▲ $73,928 |
| Total Liabilities | $19,824,763 | $29,470,044 | ▲ $9,645,281 |
| Net Assets / Fund Balance | |||
| Net Assets Without Donor Restrictions | $17,099,842 | $10,885,204 | ▼ $6,214,638 |
| Net Assets With Donor Restrictions | $10,817,339 | $10,817,339 | → $0 |
| Total Net Assets Fund Balance | $27,917,181 | $21,702,543 | ▼ $6,214,638 |
| Total Liabilities and Net Assets / Fund Balance | $47,741,944 | $51,172,587 | ▲ $3,430,643 |
| Asset | Book Value | Depreciation | Basis |
|---|---|---|---|
| Equipment | - | $11,170 | $11,170 |
| Other Assets Org | $5,798,781 | - | - |
| Period | Beginning | Contrib. | Gain/Loss | Other Uses | End |
|---|---|---|---|---|---|
| 2024 | $10,817,339 | - | - | - | $10,817,339 |
| 2023 | $10,817,339 | - | - | - | $10,817,339 |
| 2022 | $10,817,339 | - | - | - | $10,817,339 |
| 2021 | $10,817,339 | - | - | - | $10,817,339 |
| 2020 | $10,817,339 | - | - | - | $10,817,339 |
| Name | Title | Full / Part Time | Base | Other | Total |
|---|---|---|---|---|---|
| Lynn P Carter | Trustee | - | $186,901 | $708,180 | $203,349 |
| Jarred W Sloan | Trustee, Vice President, Treasurer | - | $150,341 | $7,790 | $161,305 |
| Joan S Dunlap | Trustee,VP,Assistant Secretary | PT | $129,182 | $16,448 | $136,972 |
| John Russell Beekman | Vice President | PT | $77,248 | $158,048 | $77,248 |
| Brian W Crozier | Trustee, Chairman | PT | $77,248 | $10,964 | $77,248 |
| Name | Title |
|---|---|
| Robert M Wallace | Trustee, President |
| Christopher MacKenzie | Vice President, Secretary |
| Robert L Evans Jr | VP, Assistant Treasurer |
| Contractor | Services | Location | Compensation |
|---|---|---|---|
| Norton Rose Fulbright LLP | Legal Services | 98 San Jacinto Suite1100, Austin, TX 78701 | $3,651,537 |
| Clayton Biotechnologies Inc | Consulting | One Riverway Suite 1520, Houston, TX 77056 | $3,425,000 |
| Parker Highlander PLLC | Legal service - medical patent | 1120 S Capital of Texas Highway, Austin, TX 78746 | $1,306,893 |
| Line Item | Amount |
|---|---|
| Other Expenses | $15,002,605 |
| Salaries, Compensation, and Employee Benefits | $702,127 |
| Grants and Similar Amounts Paid | $250,000 |
| Professional Fundraising Fees | $0 |
| Total Fundraising Expense | $0 |
| Line Item | Program | Management | Fundraising | Total |
|---|---|---|---|---|
| Fees for Services Legal | $4,645,353 | $18,271 | - | $4,663,624 |
| Fees for Services Other | $3,425,000 | $12,753 | - | $3,437,753 |
| Other Expenses | $1,476,927 | - | - | $1,476,927 |
| Current Officers, Directors, Trustees, and Key Employees | $492,087 | $164,029 | - | $656,116 |
| Grants to Domestic Orgs | $250,000 | - | - | $250,000 |
| Insurance | $52,507 | $23,590 | - | $76,097 |
| Fees for Services Accounting | - | $32,000 | - | $32,000 |
| Fees for Service Investment Mgmnt Fees | - | $30,497 | - | $30,497 |
| Comp Disqual Persons | $25,252 | $2,806 | - | $28,058 |
| Occupancy | - | $21,000 | - | $21,000 |
| Payroll Taxes | $13,465 | $4,488 | - | $17,953 |
| Office Expenses | - | $4,816 | - | $4,816 |
| Travel | $1,268 | $1,268 | - | $2,536 |
| Total Functional Expenses | $15,639,214 | $315,518 | $0 | $15,954,732 |
| Line Item | Amount |
|---|---|
| Total Expenses per Form 990 | $15,954,732 |
| Expenses per Audited Statements | $15,355,823 |
| Total Expenses per Audited Statements | $15,355,823 |
| Expenses Not Reported on Financial Statements | $598,909 |
| Other Expense Adjustments | $568,412 |
| Recipient | Location | Category | Purpose | Amount |
|---|---|---|---|---|
| Foundation for Research | Carson City, NV | 501(c)(3) | General Support | $250,000 |
| Line Item | Amount |
|---|---|
| Professional Fundraising Fees | $0 |
| Interested Party | Relationship | Description | Shared Revenue | Amount |
|---|---|---|---|---|
| Allison MacKenzie Ltd | See Schedule O | Legal & Admin Services | No | $95,315 |
| Brorby Crozier Dobie PC | See Schedule O | Legal services | No | $28,058 |
| Line Item | Beginning | End | Change |
|---|---|---|---|
| Receivables from Disqualified Persons | - | $0 | - |
| Receivables from Officers, Directors, Trustees, and Key Employees | - | $0 | - |
“Form 990 is prepared by the Foundation's accounting staff and sent to the Brorby, Crozier & Dobie law firm for review by a tax partner. Each trustee is given a copy of the return for review by the Treasurer prior to filing. Once satisfied with the content of the Form 990, the trustees approve the return for filing with the Internal Revenue Service, and the return is signed and dated by the appropriate officer of the Foundation.”
“Annually, the trustees and officers review the Conflicts of Interest Policy adopted by the Foundation. At a meeting of the Board each year, both the trustees and the officers sign and date a statement which affirms that such person has received a copy of the conflict of interest policy, has read and understands the policy, has agreed to comply with the policy, and understands that the Foundation is a charitable organization and that in order to maintain its federal tax exemption it must engage primarily in activities which accomplish one of more of its tax-exempt purposes. It is the policy of the Foundation to assure that any conflicts of interest or potential conflicts of interest are fully disclosed to the Board before a decision is made or before the Foundation enters into a proposed transaction. Where necessary to determine whether a conflict of interest exists, after disclosure of the financial interest and all material facts, and after any discussion with the interested person, he or she leaves the Board meeting while the determination of whether a conflict of interest exists is discussed. If the Board determines that a conflict exists, the Board then determines whether the transaction or arrangement is fair and reasonable and should be permitted despite the conflict (or not) as being in the best interests of the Foundation. In instances where the Board has determined that a member has failed to disclose an actual or possible conflict of interest, it will take appropriate disciplinary and/or corrective action.”
“Several written opinions have been obtained from well recognized independent accounting and consulting firms as to the reasonableness of the compensation being paid to the officers and trustees of the Foundation (including amounts paid by related organizations). In addition, all steps listed in the regulations under IRC Section 4958 (including approval by a compensation committee composed of disinterested persons) have been taken to obtain the rebuttable presumption that compensation paid to the trustees and officers is reasonable. More specifically, the Foundation has periodically engaged an independent consulting firm to review the compensation of the officers and trustees of the Foundation and the group of related and supporting entities. Such consulting firm examines the relevant facts and collects information and data from the Foundation. It also collects and analyzes compensation data from a peer group of unrelated non-profit and for-profit organizations that it selects for comparability purposes. Such firm then renders a written report and opinion containing its conclusions and recommendations. Such report (including a thorough description of the facts and the comparability analysis and data) is provided to the Foundation's Compensation Committee. Such committee, which has the sole authority to approve officer and trustee compensation, constitutes an authorized body composed of persons that do not have a conflict of interest with respect to such compensation arrangements under the rules and requirements set forth in Reg. 53.4958-6(c)(1). The committee meets and reviews the consulting firm's report and the comparability analysis and data. At the meeting, the committee has the opportunity to ask questions and request additional information from a Foundation representative on the committee (who recuses himself from the meeting before any action is taken). After review of the relevant documents and data and after deliberations, the independent committee members make the determination with respect to the amount and reasonableness of the officer and trustee compensation arrangements. Such determination is binding on the trustees and officers of the Foundation. Detailed minutes of each Compensation Committee meeting are contemporaneously prepared and maintained in the Foundation's files.”
“See Line 15 a for the description of the compensation review and approval of other officers or key employees.”
“No documents available to the public.”
“The recommendation regarding independent members of the governing board of a charity is described and discussed in detail in the report entitled "Principles for Good Governance and Ethical Practice, A Guide for Charities and Foundations", Reference Edition, that was published in October 2007 by the Panel on the Nonprofit Sector. This panel was convened by Independent Sector and its recommendations have been cited with approval by the Internal Revenue Service. Such report concludes that the principle with respect to independent directors does not apply to various types of organizations, including supporting organizations such as the Foundation, as to which the requirements of IRC Section 509(a)(3) require common Board members. In this regard, Footnote 27 on page 23 expressly states as follows: "This principle [a substantial majority of the Board should be independent] does not apply to private foundations; medical research institutions... supporting organizations or subsidiaries that are required by law to include representatives of the supported organizations or sponsoring charities on their board... "[footnote listing continues with several other specific types of Section 501(c)(3) organizations].”
“Each of the trustees and officers of the Foundation also serve as trustees, directors and/or officers of the various related organizations listed in Schedule R. Mr. Christopher MacKenzie, Vice President and Secretary of the Foundation, is a partner in the law firm of Allison, MacKenzie, Ltd. Mr. MacKenzie was elected in October 2013. Allison, MacKenzie, Ltd. is engaged to represent the Foundation in various legal and administrative matters, as well as leasing office space to the Foundation at rates determined by arm's length negotiation. The Foundation's relationship with Allison, MacKenzie, Ltd. predates the naming of Mr. Christopher MacKenzie as an officer. Mr. Brian W. Crozier, who became a trustee of the Foundation on January 1, 2019 and who was elected chairman in April 2023, has provided legal services to the Foundation or its supported organization since 1985. Mr. Crozier is a member of the law firm of Brorby, Crozier & Dobie, P.C. ("B,C&D") owning more than 35 of B,C&D. Such firm is engaged to furnish legal services to the Foundation on an hourly basis in connection with various matters upon the request of Foundation trustees and officers other than Mr. Crozier. The Foundation's relationship with B,C&D pre-dates the naming of Mr. Crozier as a trustee. In his capacity as a member of the Board of the Foundation, Mr. Crozier has not participated in any decisions involving assignment of work to B,C&D and have not been involved in the review and approval of the detailed monthly invoices sent by B,C&D to the Foundation. In his capacity with B,C&D, Mr. Crozier has not participated in the preparation of the monthly statements of amounts billed to the Foundation. The other trustees (with Mr. Crozier abstaining) have approved this arrangement with full knowledge of Mr. Crozier's position as a member of and a holder of a financial interest in B,C&D. Several written opinions have been obtained from well recognized independent accounting and consulting firms as to the reasonableness of the legal fees being paid to B,C&D by the Foundation. In addition, all steps listed in the regulations under IRC Section 4958 (including approval by a compensation committee composed of disinterested persons) have been taken to obtain the rebuttable presumption that compensation paid to B,C&D is reasonable. More specifically, the Foundation has periodically engaged an independent consulting firm to review the legal fees paid to B,C&D. Such consulting firm examines the relevant facts and collects information and data from the Foundation and B,C&D. It also collects and analyzes compensation data from a peer group of comparable unrelated attorneys and law firms that it selects for comparability purposes. Such consulting firm then renders a written report and opinion containing its conclusions and recommendations. Such report (including a thorough description of the facts and the comparability analysis and data) is provided to the Foundation's Compensation Committee. Such committee, which has the sole authority to approve the compensation arrangement with B,C&D (including hourly rates), constitutes an authorized body composed of persons that do not have a conflict of interest with respect to such compensation arrangements under the rules and requirements set forth in Reg. 53.4958-6(c)(1). The committee meets and reviews the consulting firm's report and the comparability analysis and data. At the meeting, the committee has the opportunity to ask questions and request additional information from a Foundation representative on the committee (who recuses himself from the meeting before any action is taken). After review of the relevant documents and data and after deliberations, the independent committee members make the determination with respect to the amounts and reasonableness of the compensation arrangement. Such determination is binding on B,C&D. Detailed minutes of each compensation committee are contemporaneously prepared and maintained in the Founda”
“Patent cost over Amort. and Abandonment = $568412”
“The Board of Trustees of the Foundation has interpreted the Uniform Prudent Management of Institutional Funds Act (UPMIFA) as requiring the preservation of the fair value of the original donor contribution as of the contribution date of the donor-restricted endowment funds. As a result of this interpretation, the Foundation classifies as permanently restricted net assets the original value of the donated contribution to the permanent endowment. Accordingly only the income, including realized and unrealized gains, is to be used for the Foundation's activities, except when such assets must be distributed in order to maintain the Foundation's tax-exempt status.”
“From the Federal Income Taxes section of the notes to the financial statements:"The Foundation has no uncertain tax provisions".”
“Patent cost over amort. & abandonments $568412”
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990/AccountantCompileOrReviewInd | 0 | false |
| IRS990/AccountsPayableAccrExpnssGrp/BOYAmt | 0 | 1047824 |
| IRS990/AccountsPayableAccrExpnssGrp/EOYAmt | 0 | 1121752 |
| IRS990/AccountsReceivableGrp/BOYAmt | 0 | 1155022 |
| IRS990/AccountsReceivableGrp/EOYAmt | 0 | 1826912 |
| IRS990/ActivitiesConductedPrtshpInd | 0 | false |
| IRS990/ActivityOrMissionDesc | 0 | To advance medical and scientific research through the transfer of technology from the laboratory to public use by obtaining patents, granting licenses and administering patents arising out of discoveries pursuant to research conducted or sponsored by certain other charitable organizations. As funds are available, grants are made to Clayton Foundation for Research to support additional research. |
| IRS990/AdvertisingGrp/TotalAmt | 0 | 0 |
| IRS990/AllOtherExpensesGrp/TotalAmt | 0 | 0 |
| IRS990/AnnualDisclosureCoveredPrsnInd | 0 | true |
| IRS990/AuditCommitteeInd | 0 | true |
| IRS990/BackupWthldComplianceInd | 0 | true |
| IRS990/BenefitsToMembersGrp/TotalAmt | 0 | 0 |
| IRS990/BooksInCareOfDetail/PersonNm | 0 | J Russell Beekman |
| IRS990/BooksInCareOfDetail/PhoneNum | 0 | 7753293111 |
| IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 1325 Airmotive Way Suite 175 |
| IRS990/BooksInCareOfDetail/USAddress/CityNm | 0 | Reno |
| IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | NV |
| IRS990/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 89502 |
| IRS990/BusinessRlnWith35CtrlEntInd | 0 | true |
| IRS990/BusinessRlnWithFamMemInd | 0 | false |
| IRS990/BusinessRlnWithOrgMemInd | 0 | false |
| IRS990/CashNonInterestBearingGrp/BOYAmt | 0 | 432263 |
| IRS990/CashNonInterestBearingGrp/EOYAmt | 0 | 261881 |
| IRS990/ChangeToOrgDocumentsInd | 0 | false |
| IRS990/CntrctRcvdGreaterThan100KCnt | 0 | 3 |
| IRS990/CollectionsOfArtInd | 0 | false |
| IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt | 0 | 164029 |
| IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt | 0 | 492087 |
| IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt | 0 | 656116 |
| IRS990/CompDisqualPersonsGrp/ManagementAndGeneralAmt | 0 | 2806 |
| IRS990/CompDisqualPersonsGrp/ProgramServicesAmt | 0 | 25252 |
| IRS990/CompDisqualPersonsGrp/TotalAmt | 0 | 28058 |
| IRS990/CompensationFromOtherSrcsInd | 0 | false |
| IRS990/CompensationProcessCEOInd | 0 | true |
| IRS990/CompensationProcessOtherInd | 0 | true |
| IRS990/ConferencesMeetingsGrp/TotalAmt | 0 | 0 |
| IRS990/ConflictOfInterestPolicyInd | 0 | true |
| IRS990/ConservationEasementsInd | 0 | false |
| IRS990/ConsolidatedAuditFinclStmtInd | 0 | false |
| IRS990/ContractorCompensationGrp/CompensationAmt | 0 | 3425000 |
| IRS990/ContractorCompensationGrp/CompensationAmt | 1 | 1306893 |
| IRS990/ContractorCompensationGrp/CompensationAmt | 2 | 3651537 |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt | 0 | One Riverway Suite 1520 |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt | 1 | 1120 S Capital of Texas Highway |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt | 2 | 98 San Jacinto Suite1100 |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm | 0 | Houston |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm | 1 | Austin |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm | 2 | Austin |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd | 0 | TX |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd | 1 | TX |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd | 2 | TX |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd | 0 | 77056 |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd | 1 | 78746 |
| IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd | 2 | 78701 |
| IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt | 0 | Clayton Biotechnologies Inc |
| IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt | 1 | Parker Highlander PLLC |
| IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt | 2 | Norton Rose Fulbright LLP |
| IRS990/ContractorCompensationGrp/ServicesDesc | 0 | Consulting |
| IRS990/ContractorCompensationGrp/ServicesDesc | 1 | Legal service - medical patent |
| IRS990/ContractorCompensationGrp/ServicesDesc | 2 | Legal Services |
| IRS990/CreditCounselingInd | 0 | false |
| IRS990/CYBenefitsPaidToMembersAmt | 0 | 0 |
| IRS990/CYContributionsGrantsAmt | 0 | 3935000 |
| IRS990/CYGrantsAndSimilarPaidAmt | 0 | 250000 |
| IRS990/CYInvestmentIncomeAmt | 0 | 1472512 |
| IRS990/CYOtherExpensesAmt | 0 | 15002605 |
| IRS990/CYOtherRevenueAmt | 0 | 0 |
| IRS990/CYProgramServiceRevenueAmt | 0 | 745691 |
| IRS990/CYRevenuesLessExpensesAmt | 0 | -9801529 |
| IRS990/CYSalariesCompEmpBnftPaidAmt | 0 | 702127 |
| IRS990/CYTotalExpensesAmt | 0 | 15954732 |
| IRS990/CYTotalFundraisingExpenseAmt | 0 | 0 |
| IRS990/CYTotalProfFndrsngExpnsAmt | 0 | 0 |
| IRS990/CYTotalRevenueAmt | 0 | 6153203 |
| IRS990/DecisionsSubjectToApprovaInd | 0 | false |
| IRS990/DeductibleArtContributionInd | 0 | false |
| IRS990/DeductibleNonCashContriInd | 0 | false |
| IRS990/DeferredRevenueGrp/BOYAmt | 0 | 18776939 |
| IRS990/DeferredRevenueGrp/EOYAmt | 0 | 28348292 |
| IRS990/DelegationOfMgmtDutiesInd | 0 | false |
| IRS990/DepreciationDepletionGrp/TotalAmt | 0 | 0 |
| IRS990/Desc | 0 | Research Development Foundation (RDF) is established to transfer medical and scientific technology from the lab to the public use by obtaining patents and licenses and administering patents arising out of discoveries made pursuant to medical research conducted or sponsored by Clayton Foundation for Research, a medical research organization described in Section 170(b)(1)(A)(iii) ("Clayton"), and by supporting organizations to Clayton. RDF's current patent portfolio contains approximately 200 patent applications and issued patents on discoveries that have been made in the course of the various research projects that have been conducted by Clayton or funded by another supporting entity of Clayton over the years. RDF has entered into numerous licenses of such discoveries to pharmaceutical and startup companies and fifteen of such discoveries have already led to products that have been brought to market by the licensee and are benefiting mankind. RDF has collected millions of dollars in royalties from its licensing activities over the years. |
| IRS990/DescribedInSection501c3Ind | 0 | true |
| IRS990/DisregardedEntityInd | 0 | false |
| IRS990/DocumentRetentionPolicyInd | 0 | true |
| IRS990/DonorAdvisedFundInd | 0 | false |
| IRS990/DonorRestrictionNetAssetsGrp/BOYAmt | 0 | 10817339 |
| IRS990/DonorRestrictionNetAssetsGrp/EOYAmt | 0 | 10817339 |
| IRS990/DonorRstrOrQuasiEndowmentsInd | 0 | true |
| IRS990/ElectionOfBoardMembersInd | 0 | false |
| IRS990/EmployeeCnt | 0 | 3 |
| IRS990/EmploymentTaxReturnsFiledInd | 0 | true |
| IRS990/EngagedInExcessBenefitTransInd | 0 | false |
| IRS990/ExpenseAmt | 0 | 15639214 |
| IRS990/FamilyOrBusinessRlnInd | 0 | true |
| IRS990/FederalGrantAuditRequiredInd | 0 | false |
| IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt | 0 | 32000 |
| IRS990/FeesForServicesAccountingGrp/TotalAmt | 0 | 32000 |
| IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt | 0 | 18271 |
| IRS990/FeesForServicesLegalGrp/ProgramServicesAmt | 0 | 4645353 |
| IRS990/FeesForServicesLegalGrp/TotalAmt | 0 | 4663624 |
| IRS990/FeesForServicesLobbyingGrp/TotalAmt | 0 | 0 |
| IRS990/FeesForServicesManagementGrp/TotalAmt | 0 | 0 |
| IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt | 0 | 12753 |
| IRS990/FeesForServicesOtherGrp/ProgramServicesAmt | 0 | 3425000 |
| IRS990/FeesForServicesOtherGrp/TotalAmt | 0 | 3437753 |
| IRS990/FeesForServicesProfFundraising/TotalAmt | 0 | 0 |
| IRS990/FeesForSrvcInvstMgmntFeesGrp/ManagementAndGeneralAmt | 0 | 30497 |
| IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt | 0 | 30497 |
| IRS990/ForeignActivitiesInd | 0 | false |
| IRS990/ForeignFinancialAccountInd | 0 | false |
| IRS990/ForeignGrantsGrp/TotalAmt | 0 | 0 |
| IRS990/ForeignOfficeInd | 0 | false |
| IRS990/Form1098CFiledInd | 0 | false |
| IRS990/Form8282FiledCnt | 0 | 0 |
| IRS990/Form8282PropertyDisposedOfInd | 0 | false |
| IRS990/Form8899Filedind | 0 | false |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt | 0 | 36.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt | 1 | 36.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt | 2 | 36.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt | 3 | 32.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt | 4 | 9.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt | 5 | 40.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt | 6 | 30.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt | 7 | 2.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 0 | 4.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 1 | 4.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 2 | 4.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 3 | 8.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 4 | 6.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 5 | 0.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 6 | 10.00 |
| IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt | 7 | 1.00 |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 0 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 1 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 2 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 3 | X |
| IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd | 4 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 0 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 1 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 2 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 3 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 4 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 5 | X |
| IRS990/Form990PartVIISectionAGrp/OfficerInd | 6 | X |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 0 | 99413 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 1 | 99413 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 2 | 99413 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 3 | 89294 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 4 | 49850 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 5 | 83150 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 6 | 40505 |
| IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt | 7 | 0 |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 0 | Robert M Wallace |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 1 | Jarred W Sloan |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 2 | Lynn P Carter |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 3 | Joan S Dunlap |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 4 | Brian W Crozier |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 5 | Robert L Evans Jr |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 6 | John Russell Beekman |
| IRS990/Form990PartVIISectionAGrp/PersonNm | 7 | Christopher MacKenzie |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 0 | 186901 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 1 | 150341 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 2 | 77248 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 3 | 129182 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 4 | 77248 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 5 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 6 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt | 7 | 0 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 0 | 499114 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 1 | 535674 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 2 | 608767 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 3 | 488563 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 4 | 279800 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 5 | 222000 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 6 | 117543 |
| IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt | 7 | 0 |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 0 | Trustee, President |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 1 | Trustee, Vice President, Treasurer |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 2 | Trustee |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 3 | Trustee,VP,Assistant Secretary |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 4 | Trustee, Chairman |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 5 | VP, Assistant Treasurer |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 6 | Vice President |
| IRS990/Form990PartVIISectionAGrp/TitleTxt | 7 | Vice President, Secretary |
| IRS990/Form990ProvidedToGvrnBodyInd | 0 | true |
| IRS990/FormationYr | 0 | 1989 |
| IRS990/FormerOfcrEmployeesListedInd | 0 | false |
| IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd | 0 | X |
| IRS990/FSAuditedInd | 0 | true |
| IRS990/FundraisingActivitiesInd | 0 | false |
| IRS990/GamingActivitiesInd | 0 | false |
| IRS990/GoverningBodyVotingMembersCnt | 0 | 5 |
| IRS990/GrantAmt | 0 | 250000 |
| IRS990/GrantsToDomesticIndividualsGrp/TotalAmt | 0 | 0 |
| IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt | 0 | 250000 |
| IRS990/GrantsToDomesticOrgsGrp/TotalAmt | 0 | 250000 |
| IRS990/GrantsToIndividualsInd | 0 | false |
| IRS990/GrantsToOrganizationsInd | 0 | true |
| IRS990/GrantToRelatedPersonInd | 0 | false |
| IRS990/GrossReceiptsAmt | 0 | 6153203 |
| IRS990/GroupReturnForAffiliatesInd | 0 | false |
| IRS990/IncludeFIN48FootnoteInd | 0 | true |
| IRS990/IncmFromInvestBondProceedsGrp/TotalRevenueColumnAmt | 0 | 0 |
| IRS990/IndependentAuditFinclStmtInd | 0 | true |
| IRS990/IndependentVotingMemberCnt | 0 | 0 |
| IRS990/IndivRcvdGreaterThan100KCnt | 0 | 3 |
| IRS990/IndoorTanningServicesInd | 0 | false |
| IRS990/InfoInScheduleOPartIXInd | 0 | X |
| IRS990/InfoInScheduleOPartVIInd | 0 | X |
| IRS990/InfoInScheduleOPartXIInd | 0 | X |
| IRS990/InformationTechnologyGrp/TotalAmt | 0 | 0 |
| IRS990/InsuranceGrp/ManagementAndGeneralAmt | 0 | 23590 |
| IRS990/InsuranceGrp/ProgramServicesAmt | 0 | 52507 |
| IRS990/InsuranceGrp/TotalAmt | 0 | 76097 |
| IRS990/IntangibleAssetsGrp/EOYAmt | 0 | 0 |
| IRS990/InterestGrp/TotalAmt | 0 | 0 |
| IRS990/InventoriesForSaleOrUseGrp/EOYAmt | 0 | 0 |
| IRS990/InvestmentIncomeGrp/ExclusionAmt | 0 | 1472512 |
| IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt | 0 | 1472512 |
| IRS990/InvestmentInJointVentureInd | 0 | false |
| IRS990/InvestmentsOtherSecuritiesGrp/EOYAmt | 0 | 0 |
| IRS990/InvestmentsProgramRelatedGrp/EOYAmt | 0 | 0 |
| IRS990/InvestmentsPubTradedSecGrp/BOYAmt | 0 | 26295220 |
| IRS990/InvestmentsPubTradedSecGrp/EOYAmt | 0 | 29319817 |
| IRS990/IRPDocumentCnt | 0 | 15 |
| IRS990/IRPDocumentW2GCnt | 0 | 0 |
| IRS990/LandBldgEquipAccumDeprecAmt | 0 | 11170 |
| IRS990/LandBldgEquipBasisNetGrp/EOYAmt | 0 | 0 |
| IRS990/LandBldgEquipCostOrOtherBssAmt | 0 | 11170 |
| IRS990/LegalDomicileStateCd | 0 | NV |
| IRS990/LoanOutstandingInd | 0 | false |
| IRS990/LobbyingActivitiesInd | 0 | false |
| IRS990/LocalChaptersInd | 0 | false |
| IRS990/MaterialDiversionOrMisuseInd | 0 | false |
| IRS990/MembersOrStockholdersInd | 0 | false |
| IRS990/MethodOfAccountingAccrualInd | 0 | X |
| IRS990/MinutesOfCommitteesInd | 0 | true |
| IRS990/MinutesOfGoverningBodyInd | 0 | true |
| IRS990/MissionDesc | 0 | To advance medical and scientific research through the transfer of technology from the laboratory to public use by obtaining patents and licenses and administering patents arising out of discoveries made pursuant to research conducted or sponsored by Clayton Foundation for Research and its supporting organizations. |
| IRS990/MoreThan5000KToIndividualsInd | 0 | false |
| IRS990/MoreThan5000KToOrgInd | 0 | false |
| IRS990/NetAssetsOrFundBalancesBOYAmt | 0 | 27917181 |
| IRS990/NetAssetsOrFundBalancesEOYAmt | 0 | 21702543 |
| IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt | 0 | 0 |
| IRS990/NetIncmFromFundraisingEvtGrp/TotalRevenueColumnAmt | 0 | 0 |
| IRS990/NetIncomeFromGamingGrp/TotalRevenueColumnAmt | 0 | 0 |
| IRS990/NetIncomeOrLossGrp/TotalRevenueColumnAmt | 0 | 0 |
| IRS990/NetRentalIncomeOrLossGrp/TotalRevenueColumnAmt | 0 | 0 |
| IRS990/NetUnrlzdGainsLossesInvstAmt | 0 | 3018479 |
| IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt | 0 | 17099842 |
| IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt | 0 | 10885204 |
| IRS990/NondeductibleContributionsInd | 0 | false |
| IRS990/OccupancyGrp/ManagementAndGeneralAmt | 0 | 21000 |
| IRS990/OccupancyGrp/TotalAmt | 0 | 21000 |
| IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt | 0 | 4816 |
| IRS990/OfficeExpensesGrp/TotalAmt | 0 | 4816 |
| IRS990/OfficerMailingAddressInd | 0 | false |
| IRS990/OperateHospitalInd | 0 | false |
| IRS990/Organization501c3Ind | 0 | X |
| IRS990/OrganizationFollowsFASB117Ind | 0 | X |
| IRS990/OtherAssetsTotalGrp/BOYAmt | 0 | 5230369 |
| IRS990/OtherAssetsTotalGrp/EOYAmt | 0 | 5798781 |
| IRS990/OtherChangesInNetAssetsAmt | 0 | 568412 |
| IRS990/OtherEmployeeBenefitsGrp/TotalAmt | 0 | 0 |
| IRS990/OtherExpensesGrp/Desc | 0 | Prejudgment Interest |
| IRS990/OtherExpensesGrp/Desc | 1 | Patent Fees - Medical Patents |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 0 | 5257355 |
| IRS990/OtherExpensesGrp/ProgramServicesAmt | 1 | 1476927 |
| IRS990/OtherExpensesGrp/TotalAmt | 0 | 5257355 |
| IRS990/OtherExpensesGrp/TotalAmt | 1 | 1476927 |
| IRS990/OtherRevenueTotalAmt | 0 | 0 |
| IRS990/OtherSalariesAndWagesGrp/TotalAmt | 0 | 0 |
| IRS990/OthNotesLoansReceivableNetGrp/EOYAmt | 0 | 0 |
| IRS990/PartialLiquidationInd | 0 | false |
| IRS990/PaymentsToAffiliatesGrp/TotalAmt | 0 | 0 |
| IRS990/PayPremiumsPrsnlBnftCntrctInd | 0 | false |
| IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt | 0 | 4488 |
| IRS990/PayrollTaxesGrp/ProgramServicesAmt | 0 | 13465 |
| IRS990/PayrollTaxesGrp/TotalAmt | 0 | 17953 |
| IRS990/PensionPlanContributionsGrp/TotalAmt | 0 | 0 |
| IRS990/PledgesAndGrantsReceivableGrp/EOYAmt | 0 | 0 |
| IRS990/PoliticalCampaignActyInd | 0 | false |
| IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt | 0 | 92211 |
| IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt | 0 | 51199 |
| IRS990/PrincipalOfficerNm | 0 | Robert M Wallace |
| IRS990/ProfessionalFundraisingInd | 0 | false |
| IRS990/ProgramServiceRevenueGrp/BusinessCd | 0 | 900099 |
| IRS990/ProgramServiceRevenueGrp/Desc | 0 | Technology royalty income |
| IRS990/ProgramServiceRevenueGrp/ExclusionAmt | 0 | 745691 |
| IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt | 0 | 745691 |
| IRS990/ProhibitedTaxShelterTransInd | 0 | false |
| IRS990/PYExcessBenefitTransInd | 0 | false |
| IRS990/PYGrantsAndSimilarPaidAmt | 0 | 8600000 |
| IRS990/PYInvestmentIncomeAmt | 0 | 2283971 |
| IRS990/PymtTravelEntrtnmntPubOfclGrp/TotalAmt | 0 | 0 |
| IRS990/PYOtherExpensesAmt | 0 | 7495350 |
| IRS990/PYProgramServiceRevenueAmt | 0 | 2516111 |
| IRS990/PYRevenuesLessExpensesAmt | 0 | -12002428 |
| IRS990/PYSalariesCompEmpBnftPaidAmt | 0 | 707160 |
| IRS990/PYTotalExpensesAmt | 0 | 16802510 |
| IRS990/PYTotalRevenueAmt | 0 | 4800082 |
| IRS990/QuidProQuoContributionsInd | 0 | false |
| IRS990/RcvblFromDisqualifiedPrsnGrp/EOYAmt | 0 | 0 |
| IRS990/RcvFndsToPayPrsnlBnftCntrctInd | 0 | false |
| IRS990/ReceivablesFromOfficersEtcGrp/EOYAmt | 0 | 0 |
| IRS990/ReconcilationRevenueExpnssAmt | 0 | -9801529 |
| IRS990/RegularMonitoringEnfrcInd | 0 | true |
| IRS990/RelatedEntityInd | 0 | true |
| IRS990/RelatedOrganizationCtrlEntInd | 0 | false |
| IRS990/RelatedOrganizationsAmt | 0 | 3935000 |
| IRS990/ReportInvestmentsOtherSecInd | 0 | false |
| IRS990/ReportLandBuildingEquipmentInd | 0 | true |
| IRS990/ReportOtherAssetsInd | 0 | true |
| IRS990/ReportOtherLiabilitiesInd | 0 | false |
| IRS990/ReportProgramRelatedInvstInd | 0 | false |
| IRS990/RoyaltiesGrp/TotalAmt | 0 | 0 |
| IRS990/RoyaltiesRevenueGrp/TotalRevenueColumnAmt | 0 | 0 |
| IRS990/SavingsAndTempCashInvstGrp/BOYAmt | 0 | 14536859 |
| IRS990/SavingsAndTempCashInvstGrp/EOYAmt | 0 | 13913997 |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/Contribution35ControlledInd | 0 | false |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/ContributionControllerInd | 0 | false |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/ContributionFamilyInd | 0 | false |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/ControlledDisqualifiedPrsnInd | 0 | false |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/DisqualifiedPrsnControllIntInd | 0 | false |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/DisqualifiedPrsnOwnrIntInd | 0 | false |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/ExcessBusinessHoldingsRulesInd | 0 | false |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/ListedByNameGoverningDocInd | 0 | false |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/LoanDisqualifiedPersonInd | 0 | false |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/OrganizationChangeSuprtOrgInd | 0 | false |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/PaymentSubstantialContribtrInd | 0 | false |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportedOrgNotOrganizedUSInd | 0 | false |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportedOrgSectionC456Ind | 0 | false |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/SupportNonSupportedOrgInd | 0 | false |
| IRS990ScheduleA/Form990SchASupportingOrgGrp/SuprtOrgNoIRSDeterminationInd | 0 | false |
| IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt | 0 | A grant of $250,000 was made to Foundation for Research. Remaining functional expenses of $15,389,214 incurred in connection with patent and licensing function for the benefit of Clayton Foundation for Research and its supporting entities. |
| IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt | 1 | Research Development Foundation is limited to supporting activities of a Clayton Foundation for Research, (a) medical research organization described in Section 170(b)(1)(A)(iii), (b) Foundation for Research, (c) Clayton Medical Research Foundation, and (d) hospitals, medical and scientific schools and organizations which conduct or support medical or scientific research described in Section 501(c)(3) of the Internal Revenue Code and classified as other than private foundations under Sections 509(a)(1) or 509(a)(2) of the Code. Foundation for Research and Clayton Medical Research Foundation are related tax-exempt organizations (see Schedule R) that are also Type II supporting organizations to Clayton Foundation for Research. |
| IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc | 0 | Support Schedule: Additional Supplemental Information |
| IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc | 1 | Part IV, Section A, Line 1: Description Of How Supported Organizations Are Desigated |
| IRS990ScheduleA/IRSWrittenDeterminationInd | 0 | X |
| IRS990ScheduleA/MajorityDirTrstSupportedOrgInd | 0 | true |
| IRS990ScheduleA/OtherSupportSumAmt | 0 | 0 |
| IRS990ScheduleA/SupportedOrganizationsCnt | 0 | 1 |
| IRS990ScheduleA/SupportedOrganizationsTotalCnt | 0 | 1 |
| IRS990ScheduleA/SupportedOrgInformationGrp/EIN | 0 | 741541767 |
| IRS990ScheduleA/SupportedOrgInformationGrp/GoverningDocumentListedInd | 0 | true |
| IRS990ScheduleA/SupportedOrgInformationGrp/OrganizationTypeCd | 0 | 4 |
| IRS990ScheduleA/SupportedOrgInformationGrp/OtherSupportAmt | 0 | 0 |
| IRS990ScheduleA/SupportedOrgInformationGrp/SupportAmt | 0 | 15639214 |
| IRS990ScheduleA/SupportedOrgInformationGrp/SupportedOrganizationName/BusinessNameLine1Txt | 0 | Clayton Foundation for Research |
| IRS990ScheduleA/SupportingOrganization509a3Ind | 0 | X |
| IRS990ScheduleA/SupportingOrgType2Ind | 0 | X |
| IRS990ScheduleA/SupportSumAmt | 0 | 15639214 |
| IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorNum | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine1 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine2 | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode | 0 | RESTRICTED |
| IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt | 0 | RESTRICTED |
| IRS990/ScheduleBRequiredInd | 0 | true |
| IRS990ScheduleD/CYEndwmtFundGrp/BeginningYearBalanceAmt | 0 | 10817339 |
| IRS990ScheduleD/CYEndwmtFundGrp/EndYearBalanceAmt | 0 | 10817339 |
| IRS990ScheduleD/CYMinus1YrEndwmtFundGrp/BeginningYearBalanceAmt | 0 | 10817339 |
| IRS990ScheduleD/CYMinus1YrEndwmtFundGrp/EndYearBalanceAmt | 0 | 10817339 |
| IRS990ScheduleD/CYMinus2YrEndwmtFundGrp/BeginningYearBalanceAmt | 0 | 10817339 |
| IRS990ScheduleD/CYMinus2YrEndwmtFundGrp/EndYearBalanceAmt | 0 | 10817339 |
| IRS990ScheduleD/CYMinus3YrEndwmtFundGrp/BeginningYearBalanceAmt | 0 | 10817339 |
| IRS990ScheduleD/CYMinus3YrEndwmtFundGrp/EndYearBalanceAmt | 0 | 10817339 |
| IRS990ScheduleD/CYMinus4YrEndwmtFundGrp/BeginningYearBalanceAmt | 0 | 10817339 |
| IRS990ScheduleD/CYMinus4YrEndwmtFundGrp/EndYearBalanceAmt | 0 | 10817339 |
| IRS990ScheduleD/EndowmentsHeldRelatedOrgInd | 0 | false |
| IRS990ScheduleD/EndowmentsHeldUnrelatedOrgInd | 0 | false |
| IRS990ScheduleD/EquipmentGrp/DepreciationAmt | 0 | 11170 |
| IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt | 0 | 11170 |
| IRS990ScheduleD/ExpensesNotRptFinclStmtAmt | 0 | 598909 |
| IRS990ScheduleD/ExpensesSubtotalAmt | 0 | 15355823 |
| IRS990ScheduleD/FootnoteTextInd | 0 | X |
| IRS990ScheduleD/InvestmentExpensesNotIncld2Amt | 0 | 30497 |
| IRS990ScheduleD/InvestmentExpensesNotIncldAmt | 0 | 30497 |
| IRS990ScheduleD/NetUnrealizedGainsInvstAmt | 0 | 3018479 |
| IRS990ScheduleD/OtherAssetsOrgGrp/BookValueAmt | 0 | 5798781 |
| IRS990ScheduleD/OtherAssetsOrgGrp/Desc | 0 | Med. Patent Cost net amort.of $3,867,042 |
| IRS990ScheduleD/OtherExpensesNotIncludedAmt | 0 | 568412 |
| IRS990ScheduleD/PrmnntEndowmentBalanceEOYPct | 0 | 1.00000 |
| IRS990ScheduleD/RelatedOrgListSchRInd | 0 | false |
| IRS990ScheduleD/RevenueNotReportedAmt | 0 | 3018479 |
| IRS990ScheduleD/RevenueNotReportedFinclStmtAmt | 0 | 30497 |
| IRS990ScheduleD/RevenueSubtotalAmt | 0 | 6122706 |
| IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt | 0 | The Board of Trustees of the Foundation has interpreted the Uniform Prudent Management of Institutional Funds Act (UPMIFA) as requiring the preservation of the fair value of the original donor contribution as of the contribution date of the donor-restricted endowment funds. As a result of this interpretation, the Foundation classifies as permanently restricted net assets the original value of the donated contribution to the permanent endowment. Accordingly only the income, including realized and unrealized gains, is to be used for the Foundation's activities, except when such assets must be distributed in order to maintain the Foundation's tax-exempt status. |
| IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt | 1 | From the Federal Income Taxes section of the notes to the financial statements:"The Foundation has no uncertain tax provisions". |
| IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt | 2 | Patent cost over amort. & abandonments $568412 |
| IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | Part V, Line 4: Intended uses of the endowment fund. |
| IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc | 1 | Part X : FIN48 Footnote |
| IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc | 2 | Part XII, Line 4b: Other revenue amounts included on 990 but not included in F/S |
| IRS990ScheduleD/TotalBookValueOtherAssetsAmt | 0 | 5798781 |
| IRS990ScheduleD/TotalExpensesPerForm990Amt | 0 | 15954732 |
| IRS990ScheduleD/TotalRevenuePerForm990Amt | 0 | 6153203 |
No mirrored PDF or thumbnail assets are attached yet.